AXIN2

Axin-2 · Q9Y2T1 · AXIN2 on Sugi Atlas →

381 patent compounds predicted against AXIN2, 312 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL16447499 SCHEMBL16447499 1.00 3/20
SCHEMBL11919906 SCHEMBL11919906 0.75 3/20
SCHEMBL13048281 SCHEMBL13048281 0.63 3/20
SCHEMBL27218766 SCHEMBL27218766 0.63 3/20
SCHEMBL11919934 SCHEMBL11919934 0.61 3/20
SCHEMBL27218866 SCHEMBL27218866 0.56 3/20
SCHEMBL11919898 SCHEMBL11919898 1.00 2/20
SCHEMBL11919903 SCHEMBL11919903 0.86 2/20
SCHEMBL16010756 SCHEMBL16010756 0.86 2/20
SCHEMBL11919900 SCHEMBL11919900 0.83 2/20
SCHEMBL11919910 SCHEMBL11919910 0.75 2/20
SCHEMBL11919916 SCHEMBL11919916 0.72 2/20
SCHEMBL11919921 SCHEMBL11919921 0.72 2/20
SCHEMBL11919902 SCHEMBL11919902 0.71 2/20
SCHEMBL11919917 SCHEMBL11919917 0.69 2/20
SCHEMBL11919950 SCHEMBL11919950 0.68 2/20
SCHEMBL11919951 SCHEMBL11919951 0.66 2/20
SCHEMBL11919952 SCHEMBL11919952 0.64 2/20
SCHEMBL11919953 SCHEMBL11919953 0.64 2/20
SCHEMBL11919930 SCHEMBL11919930 0.64 2/20

Clinical trials — most relevant to AXIN2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma PHASE2/PHASE3ACTIVE_NOT_RECRUITING
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer PHASE2ACTIVE_NOT_RECRUITING
Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer PHASE2UNKNOWN
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy PHASE2RECRUITING
Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel PHASE2NOT_YET_RECRUITING
Mesalazine Effects in Sporadic Colorectal Adenoma Patients PHASE2COMPLETED
CTNNB1 Neurodevelopmental Syndrome - Natural History Study nanRECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors nanNO_LONGER_AVAILABLE
Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study nanCOMPLETED
Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS nanRECRUITING
Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases nanCOMPLETED
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors nanRECRUITING
Genetic Variants of Selected Genes in Colo-Rectal Cancer Patients. nanUNKNOWN
Effect of Mechanical Ventilation on Plasma Concentration Level of R-spondin Proteins nanCOMPLETED
Development of Polygenic Risk Scores in Colon Cancer Patients Through the Study of Ancestry and Diversity in Genetic Maps of the Brazilian Population - ORIGEM Project nanENROLLING_BY_INVITATION
Exploratory Study of Rectal Mucus for Diagnosing Disease nanCOMPLETED
PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening nanCOMPLETED
Role of IMP3 Expression in Colorectal Carcinoma: An Immunohistochemical Study nanUNKNOWN
Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma. nanRECRUITING
Ohio Colorectal Cancer Prevention Initiative nanCOMPLETED
CTNNA1 Familial Expansion Study nanRECRUITING
Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study nanCOMPLETED
Early Check: Expanded Screening in Newborns nanENROLLING_BY_INVITATION
Adherence to Colon Cancer Screening (ACCS) nanCOMPLETED
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anorectal Malformations at the Colorectal Centre of Excellence in Quebec nanENROLLING_BY_INVITATION
The Activation of Hippo Pathway in Nasal Polyps nanUNKNOWN
Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines) nanUNKNOWN
Screening for Hepatitis Virus B Protein X (HBx) in Colitis-associated Cancer (CAC) nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a AXIN2 binder may also engage these)

ProteinNameSimilarity
O88566 1.000 O88566 →
O70240 1.000 O70240 →
O70239 0.998 O70239 →
P57095 0.997 P57095 →
O15169 0.996 O15169 →
P57094 0.994 P57094 →
Q9YGY0 0.994 Q9YGY0 →
O35625 0.994 O35625 →
Q9Z136 0.994 Q9Z136 →
P59281 0.992 P59281 →
Q922B9 0.992 Q922B9 →
A0M8T5 0.992 A0M8T5 →
Q09YM8 0.991 Q09YM8 →
Q8K3I4 0.991 Q8K3I4 →
Q07E15 0.991 Q07E15 →
Q9EP53 0.991 Q9EP53 →
Q155Q3 0.991 Q155Q3 →
Q09YJ3 0.991 Q09YJ3 →
Q9QY01 0.991 Q9QY01 →
A5D794 0.991 A5D794 →
Q9Y2H5 0.991 Q9Y2H5 →
Q09YG9 0.991 Q09YG9 →
P59808 0.991 P59808 →
Q09YK4 0.991 Q09YK4 →
O42400 0.991 O42400 →
Q99LJ0 0.990 Q99LJ0 →
Q2IBA2 0.990 Q2IBA2 →
Q5XJV7 0.990 Q5XJV7 →
Q07DV1 0.990 Q07DV1 →
Q8R0S2 0.990 Q8R0S2 →